Paraneoplastic Pemphigus Is a Life-Threatening Disease

Paraneoplastic pemphigus is a multiorganic autoimmune disease, usually triggered by neoplasias, mainly of lymphoproliferative origin such as chronic lymphocytic leukemia, multiple myeloma, non-Hodgkin’s lymphoma, Castleman disease, and thymoma. This disorder is characterized by the presence of autoantibodies that react against proteins, such as desmoplakins, desmocollins, and others existing in cell junctions. The prognosis is reserved, and the mortality rate of the disease is very high, thus proving to be an additional challenge in the therapeutic management of onco-hematological diseases. The objective of this chapter is to solve the main clinical aspects of paraneoplastic pemphigus in lymphoproliferative hematological diseases, anatomopathological and immunofluorescence characteristics, as well as associations with the main differential diagnoses and therapeutic management. We will also describe the main differential diagnoses of paraneoplastic pemphigus, such as various types of pemphigus including induced drug, bullous pemphigoid, drug eruption, lichen planus, graft versus host disease, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In addition, the prognosis and quality of life will be mentioned.

• Publication year

  2019

• Venue

  Current Trends in Cancer Management

• Publication date

  2019-05-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.5772/INTECHOPEN.84956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Indian Journal of Dermatology, Venereology and Leprology

  2020cited by this paper
• Current Trends in Cancer Management

  2019cited by this paper
• Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches

  2018influential reference
• Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: a case report

  2018influential reference
• Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus.

  2018cited by this paper
• Paraneoplastic Pemphigus Associated with a Malignant Thymoma: A Case of Persistent and Refractory Oral Ulcerations Following Thymectomy

  2017cited by this paper
• Paraneoplastic Pemphigus with Underlying Retroperitoneal Inflammatory Myofibroblastic Tumor: A Case Report and Review of the Literature

  2017cited by this paper
• Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy

  2017influential reference
• Paraneoplastic pemphigus associated with Castleman disease: progression from mucous to mucocutaneous lesions with epitope‐spreading phenomena

  2017cited by this paper
• A Case Report on Paraneoplastic Pemphigus Associated Colonic Carcinoma

  2016cited by this paper
• Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus

  2016cited by this paper
• Childhood Pemphigus Foliaceus with Exclusive Immunoglobulin G Autoantibodies to Desmocollins

  2016cited by this paper
• Paraneoplastic pemphigus: a short review

  2016cited by this paper
• Paraneoplastic Autoimmune Multi-organ Syndrome: Association with Retroperitoneal Kaposi's Sarcoma.

  2016cited by this paper
• Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica.

  2016cited by this paper
• Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus

  2015cited by this paper
• Paraneoplastic pemphigus: Two cases of intra‐abdominal malignancy presenting solely as treatment refractory oral ulceration

  2015cited by this paper
• Posterior reversible encephalopathy syndrome--Insight into pathogenesis, clinical variants and treatment approaches.

  2015cited by this paper
• Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin.

  2015cited by this paper
• Paraneoplastic pemphigus associated with metastatic lymphoepithelioma‐like carcinoma originating from the thyroid gland

  2015cited by this paper
• Health‐related quality of life and its determinants in pemphigus: a systematic review and meta‐analysis

  2015cited by this paper
• A middle-aged man presenting with unexplained mucosal erosions and progressive dyspnoea

  2015cited by this paper
• Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis

  2015cited by this paper
• Clinical and immunological findings in 104 cases of paraneoplastic pemphigus

  2015cited by this paper
• Autoimmune blistering dermatoses as systemic diseases.

  2014cited by this paper
• Paraneoplastic pemphigus

  2013cited by this paper
• A Case Report of Paraneoplastic Pemphigus Associated with Esophageal Squamous Cell Carcinoma

  2013cited by this paper
• Laboratory diagnosis of paraneoplastic pemphigus

  2013cited by this paper
• Prognostic factors of paraneoplastic pemphigus.

  2012influential reference
• Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist

  2012cited by this paper
• Autoimmune blistering diseases of the skin.

  2012cited by this paper
• Paraneoplastic autoimmune multiorgan syndrome: 20 years after

  2011cited by this paper
• Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).

  2011influential reference
• Bullous pemphigoid.

  2011cited by this paper
• Diagnosis and treatment of lichen planus.

  2011influential reference
• Paraneoplastic pemphigus due to CD8‐positive cytotoxic T‐cell lymphoma

  2010cited by this paper
• Pénfigo paraneoplásico/síndrome multiorgánico autoinmune paraneoplásico. Presentación de dos casos en la edad infantil. Revisión de la literatura

  2010cited by this paper
• Clinical and immunopathological spectrum of paraneoplastic pemphigus

  2010influential reference
• The Protease Inhibitor Alpha-2-Macroglobuline-Like-1 Is the p170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human

  2010cited by this paper
• Constrictive bronchiolitis associated with paraneoplastic autoimmune multi‐organ syndrome

  2009cited by this paper
• Graft-versus-host disease.

  2009cited by this paper
• Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome

  2009cited by this paper
• Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

  2009cited by this paper
• Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus

  2008cited by this paper
• No mucosal involvement in a patient with paraneoplastic pemphigus associated with thymoma and myasthenia gravis

  2008cited by this paper
• Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases §

  2008cited by this paper
• Paraneoplastic pemphigus

  2007influential reference
• Genotyping of HLA‐I and HLA‐II alleles in Chinese patients with paraneoplastic pemphigus

  2007cited by this paper
• Paraneoplastic pemphigus mimicking erosive mucosal lichen planus associated with primary hepatocellular carcinoma

  2006cited by this paper
• A Novel Protease Inhibitor of the α2-Macroglobulin Family Expressed in the Human Epidermis*

  2006cited by this paper
• Antidesmoplakin antibodies in pemphigus vulgaris

  2006cited by this paper
• Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.

  2005cited by this paper
• Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.

  2005cited by this paper
• Paraneoplastic Autoimmune Multiorgan Syndrome (Paraneoplastic Pemphigus) in a Child: Case Report and Review of the Literature

  2004cited by this paper
• Continuing Professional Development Program

  2004cited by this paper
• Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations.

  2004cited by this paper
• Alemtuzumab‐induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment‐resistant B‐cell chronic lymphocytic leukaemia

  2004cited by this paper
• Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.

  2004cited by this paper
• Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus.

  2003cited by this paper
• Successful Treatment of B Cell Chronic Lymphocytic Leukemia-Associated Severe Paraneoplastic Pemphigus with Cyclosporin A

  2003cited by this paper
• Paraneoplastic Pemphigus with Bronchiolitis Obliterans in a Child

  2003cited by this paper
• Paraneoplastic pemphigus is associated with the DRB1*03 allele.

  2003cited by this paper
• A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.

  2002cited by this paper
• Paraneoplastic pemphigus in children and adolescents

  2002cited by this paper
• Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.

  2001cited by this paper
• Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.

  2001influential reference
• Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies.

  2000cited by this paper
• Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus.

  2000cited by this paper
• Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus

  2000cited by this paper
• Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.

  2000cited by this paper
• Paraneoplastic pemphigus in two patients with B‐cell non‐Hodgkin's lymphoma: Significant responses to cyclophosphamide and prednisolone

  2000cited by this paper
• Graft‐versus‐host disease‐like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus

  1999cited by this paper
• Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus.

  1998cited by this paper
• Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.

  1998cited by this paper
• Paraneoplastic pemphigus: oral involvement as the sole manifestation.

  1996cited by this paper
• Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis

  1996cited by this paper
• Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus.

  1995cited by this paper
• Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis.

  1994cited by this paper
• Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease.

  1993cited by this paper
• [Paraneoplastic pemphigus].

  1993cited by this paper
• Conjunctival involvement in paraneoplastic pemphigus.

  1992cited by this paper
• Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.

  1990cited by this paper
• Basement membrane components in lymphoid follicles: immunohistochemical demonstration and relationship to the follicular dendritic cell network.

  1989cited by this paper
• On Pemphigus

  1819cited by this paper

• A case of pemphigus vulgaris in a patient with abdominal tumor as collaborative disease

  2023cites this paper